ATE235510T1 - Integrinbindendes peptid und dessen verwendung - Google Patents

Integrinbindendes peptid und dessen verwendung

Info

Publication number
ATE235510T1
ATE235510T1 AT98933671T AT98933671T ATE235510T1 AT E235510 T1 ATE235510 T1 AT E235510T1 AT 98933671 T AT98933671 T AT 98933671T AT 98933671 T AT98933671 T AT 98933671T AT E235510 T1 ATE235510 T1 AT E235510T1
Authority
AT
Austria
Prior art keywords
binding peptide
integrin binding
lysine
peptides
integrin
Prior art date
Application number
AT98933671T
Other languages
English (en)
Inventor
Jyrki Heino
Johanna Ivaska
Jarmo Kaepylae
Original Assignee
Biotie Therapies Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biotie Therapies Corp filed Critical Biotie Therapies Corp
Application granted granted Critical
Publication of ATE235510T1 publication Critical patent/ATE235510T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/64—Cyclic peptides containing only normal peptide links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Zoology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
AT98933671T 1997-07-11 1998-07-09 Integrinbindendes peptid und dessen verwendung ATE235510T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/893,526 US6096707A (en) 1997-07-11 1997-07-11 Integrin binding peptide and use thereof
PCT/FI1998/000579 WO1999002551A1 (en) 1997-07-11 1998-07-09 Integrin binding peptide and use thereof

Publications (1)

Publication Number Publication Date
ATE235510T1 true ATE235510T1 (de) 2003-04-15

Family

ID=25401719

Family Applications (1)

Application Number Title Priority Date Filing Date
AT98933671T ATE235510T1 (de) 1997-07-11 1998-07-09 Integrinbindendes peptid und dessen verwendung

Country Status (17)

Country Link
US (1) US6096707A (de)
EP (1) EP0994898B1 (de)
JP (1) JP2001509515A (de)
KR (1) KR100571046B1 (de)
CN (1) CN1262688A (de)
AT (1) ATE235510T1 (de)
AU (1) AU748134B2 (de)
BR (1) BR9810586A (de)
CA (1) CA2295219C (de)
DE (1) DE69812630T2 (de)
ES (1) ES2195361T3 (de)
HU (1) HU225326B1 (de)
NO (1) NO20000126D0 (de)
NZ (1) NZ501767A (de)
PL (1) PL338001A1 (de)
RU (1) RU2203902C2 (de)
WO (1) WO1999002551A1 (de)

Families Citing this family (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7914814B2 (en) * 1997-09-17 2011-03-29 Strategic Science & Technologies, Llc Topical delivery of arginine of cause beneficial effects
US7387779B2 (en) 1998-06-17 2008-06-17 Beth Israel Deaconess Medical Center Anti-angiogenic proteins and fragments and methods of use thereof
US6962974B1 (en) 1998-06-17 2005-11-08 Beth Israel Deaconess Medical Center Anti-angiogenic proteins and fragments and methods of use thereof
US6759047B1 (en) 1998-06-17 2004-07-06 Beth Israel Deaconess Hospital Corp. Anti-angiogenic proteins and methods of use thereof
GB9817623D0 (en) * 1998-08-13 1998-10-07 Glaxo Group Ltd Pharmaceutical compounds
KR20030080013A (ko) * 2001-02-21 2003-10-10 에자이 가부시키가이샤 인테그린 발현 억제를 통한 혈관 신생 억제제의 효과를검정하는 방법
NZ528076A (en) * 2001-03-02 2005-09-30 Medimmune Inc Methods of preventing or treating inflammatory or autoimmune disorders by administering integrin alphav beta3 antagonists with an immunomodulatory agents, anti-inflammatory agents, TNF-alpha antagonists or CD2 binding molecules
JP2005533001A (ja) * 2002-03-04 2005-11-04 メディミューン,インコーポレーテッド インテグリンαvβ3アンタゴニストを他の物質と併用投与する癌の予防または治療方法
CA2478317A1 (en) * 2002-03-04 2003-09-18 Medimmune, Inc. Methods of preventing or treating disorders by administering an integrin .alpha.v.beta.3 antagonist in combination with an hmg-coa reductase inhibitor or a bisphosphonate
EP2270049A3 (de) 2002-04-12 2011-03-09 Medimmune, Inc. Rekombinante Anti-Interleukin-9-Antikörper
AU2003232077A1 (en) * 2002-05-06 2003-11-17 The Scripps Research Institute Cyclic peptide anti-cancer agents and methods
EP1596884A2 (de) * 2003-01-30 2005-11-23 Medimmune, Inc. Verwendung von integrin alphabeta3 antagonisten
KR101224235B1 (ko) 2003-04-11 2013-01-25 메디뮨 엘엘씨 재조합 il­9 항체 및 그의 용도
US7196061B2 (en) * 2003-09-10 2007-03-27 Wyeth Compounds that modulate neuronal growth and their uses
US7351739B2 (en) * 2004-04-30 2008-04-01 Wellgen, Inc. Bioactive compounds and methods of uses thereof
WO2006047639A2 (en) 2004-10-27 2006-05-04 Medimmune, Inc. Modulation of antibody specificity by tailoring the affinity to cognate antigens
US8987306B2 (en) * 2005-06-07 2015-03-24 The Trustees Of The University Of Pennsylvania Inhibitors of integrin alpha2beta1 based on prolyl diaminopropionic acid scaffold
AU2006254936A1 (en) * 2005-06-07 2006-12-14 The Trustees Of The University Of Pennesylvania Inhibitors of the alpha2beta1/GPIa-IIa integrin
EP1924595A2 (de) * 2005-08-12 2008-05-28 Cartela R & D AB Neue peptide und verwendungen davon
JP4826721B2 (ja) * 2005-08-18 2011-11-30 三菱電機株式会社 マンコンベアの制御装置
WO2007027742A2 (en) * 2005-08-31 2007-03-08 The Trustees Of The University Of Pennsylvania SMALL MOLECULE INTEGRIN α2βl/GPIa-IIa ANTAGONISTS
JP2009510105A (ja) 2005-09-28 2009-03-12 バイオバスキュラー インコーポレーティッド 血小板および細胞の接着、細胞移動、および炎症を阻止するための方法および組成物
KR101413746B1 (ko) * 2005-12-22 2014-07-01 노바바이오틱스 리미티드 고리형 항균 펩타이드
AU2007272970C1 (en) 2006-07-11 2013-01-10 Roy C. Levitt Rhinosinusitis prevention and therapy with proinflammatory cytokine inhibitors
PT2068889T (pt) 2006-08-10 2020-01-30 Roy C Levitt Anakinra para uso no tratamento da síndrome da bronquiolite obliterante
GB0618512D0 (en) * 2006-09-20 2006-11-01 Lexcicon Ltd Peptides
FI20075258A0 (fi) * 2007-04-17 2007-04-17 Biotie Therapies Corp Menetelmä integriiniinhibiittorirespondereiden seulomiseksi
US20110256058A1 (en) * 2007-10-17 2011-10-20 University Of Southern California Novel Peptides and Uses Thereof
US8563690B2 (en) * 2008-11-03 2013-10-22 The Board Of Trustees Of The University Of Illinois Modulation of platelet aggregation
EP2547693B1 (de) 2010-03-19 2015-03-11 H. Lee Moffitt Cancer Center & Research Institute Integrininteraktionshemmer zur krebsbehandlung
EP2678350A1 (de) * 2011-02-22 2014-01-01 Leo Pharma A/S Cyclisches peptid und konjugat daraus zur bindung an keratinozyten
WO2015048477A1 (en) 2013-09-27 2015-04-02 H. Lee Moffitt Cancer Center And Research Institute, Inc. Cyclic peptide conjugates and methods of use
JP6866296B2 (ja) * 2015-02-27 2021-04-28 ボード オブ リージェンツ, ザ ユニバーシティ オブ テキサス システムBoard Of Regents, The University Of Texas System ポリペプチド治療及びその使用
KR102958241B1 (ko) 2018-09-10 2026-04-30 레인 테라퓨틱스, 인크. Cav-1 단백질의 변형된 펩타이드 단편 및 섬유증의 치료에 있어서 이의 용도

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5179007A (en) * 1989-07-07 1993-01-12 The Texas A & M University System Method and vector for the purification of foreign proteins
WO1994014836A1 (en) * 1992-12-18 1994-07-07 Centocor, Inc. Peptide inhibitors of selectin binding
US5627263A (en) * 1993-11-24 1997-05-06 La Jolla Cancer Research Foundation Integrin-binding peptides
AU2958195A (en) * 1994-06-29 1996-01-25 Texas Biotechnology Corporation Process to inhibit binding of the integrin alpha 4 beta 1 to vcam-1 or fibronectin
WO1996040781A1 (en) * 1995-06-07 1996-12-19 Tanabe Seiyaku Co., Ltd. CYCLIC PEPTIDE INHIBITORS OF β1 AND β2 INTEGRIN-MEDIATED ADHESION

Also Published As

Publication number Publication date
PL338001A1 (en) 2000-09-25
JP2001509515A (ja) 2001-07-24
DE69812630D1 (de) 2003-04-30
HUP0002789A2 (hu) 2000-12-28
WO1999002551A1 (en) 1999-01-21
EP0994898A1 (de) 2000-04-26
KR20010015547A (ko) 2001-02-26
NO20000126L (no) 2000-01-10
EP0994898B1 (de) 2003-03-26
AU8341398A (en) 1999-02-08
US6096707A (en) 2000-08-01
DE69812630T2 (de) 2004-02-05
KR100571046B1 (ko) 2006-04-13
CA2295219A1 (en) 1999-01-21
BR9810586A (pt) 2000-09-05
HU225326B1 (en) 2006-09-28
CA2295219C (en) 2007-01-02
HUP0002789A3 (en) 2003-08-28
NO20000126D0 (no) 2000-01-10
NZ501767A (en) 2002-08-28
ES2195361T3 (es) 2003-12-01
RU2203902C2 (ru) 2003-05-10
CN1262688A (zh) 2000-08-09
AU748134B2 (en) 2002-05-30

Similar Documents

Publication Publication Date Title
DE69812630D1 (de) Integrinbindendes peptid und dessen verwendung
DK1482042T3 (da) Aktive og inaktive CC-kemokinreceptorer og nukleinsyremolekyler der koder for receptoren
DE60041505D1 (de) Inzektizide proteinen von bacillus thuringiensis
DE59903410D1 (de) Hybridprotein zur hemmung der mastzelldegranulation und dessen verwendung
NO965362L (no) Syntetiske lederpeptidsekvenser
ATE368054T1 (de) Verbindungen und methoden zur modulierung von occludin-abhängiger gewebepermeabilität
DK1265914T3 (da) WNT-1-relaterede polypeptider og nukleinsyrer, der koder for samme
DK0912176T3 (da) Anvendelse af pyridylalkan-, pyridylalken- og/eller pyridylalkynsyreamider til behandling af tumorer eller immunosuppression
ES2721172T3 (es) Una nueva clase de moléculas terapéuticas a base de proteínas
DE69326016D1 (de) Peptidinhibitoren von fibronectin und verwandten kollagen-bindenden proteinen
DE69737978D1 (de) Als 2f1 bezeichnetes rezeptorprotein
DK1129186T3 (da) Et faktor VIII-polypeptid med faktor VIII:C-aktivitet
FI961044A0 (fi) Kininogeeni-inhibiittorit
DE68917837D1 (de) Peptid-Verbindungen.
ATE355302T1 (de) N-substituierte d-aminosäuren enthaltende peptide,zur prävention der beta-strang assoziation
DK0707473T3 (da) Orale farmaceutiske præparater omfattende et protein eller et peptid, et antistof og polymerkugler
DE69940954D1 (de) Von mage-10 oder mage-8 abgeleitete hla-a2.1-bindende oligopeptide
ATE385805T1 (de) Neue peptide
FI943218A7 (fi) Kaseinomakropeptidin peptidit, mainittujen peptidien vasta-aineet ja k äytöt
DK0946591T3 (da) Klonede glucagon-lignende peptid-2 receptorer
DK0938555T3 (da) Konstruktioner og komplekser af cyclin E
BRPI0216042B8 (pt) polipeptídeo capaz de se ligar a ang-2, vetor de expressão, célula hospedeira, composição farmacêutica, e, uso dos referidos polipeptídeos.
ATE332923T1 (de) Cr1 fragmente und deren verwendung

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 0994898

Country of ref document: EP

REN Ceased due to non-payment of the annual fee